Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Sutherland

Showing results (121-130 of 205) with videos related to

Pageof 21
Sort By:
Molecular Pharmacology|September 1, 1996
D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA bindingM L Handel, C K Watts, S Sivertsen, et al.
DNA and Cell Biology|December 1, 1992
The effect of progestins on prolactin receptor gene transcription in human breast cancer cellsC J Ormandy, J Graham, P A Kelly, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1989
1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replicationJ A Eisman, M Koga, R L Sutherland, et al.
Breast Cancer Research and Treatment|January 1, 1994
Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cellsC K Watts, K J Sweeney, A Warlters, et al.
The Journal of Biological Chemistry|April 18, 1997
Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2O W Prall, B Sarcevic, E A Musgrove, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and FosM L Handel, C K Watts, A deFazio, et al.
Molecular and Cellular Biology|April 7, 1998
Mechanisms of cyclin-dependent kinase inactivation by progestinsE A Musgrove, A Swarbrick, C S Lee, et al.
Oncogene|August 18, 2009
A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genesM Böhm, W J Locke, R L Sutherland, et al.
Journal of Cellular Biochemistry|June 1, 1996
High activity, soluble, bacterially expressed human vitamin D receptor and its ligand binding domainD G Mottershead, P Polly, R J Lyons, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|April 1, 1997
The third human isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) map position 10p14-p15J Nicholl, J A Hamilton, G R Sutherland, et al.
Pageof 21

Showing results (121-130 of 205) with videos related to

Sort By:
Pageof 21
Molecular Pharmacology|September 1, 1996
D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA bindingM L Handel, C K Watts, S Sivertsen, et al.
DNA and Cell Biology|December 1, 1992
The effect of progestins on prolactin receptor gene transcription in human breast cancer cellsC J Ormandy, J Graham, P A Kelly, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1989
1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replicationJ A Eisman, M Koga, R L Sutherland, et al.
Breast Cancer Research and Treatment|January 1, 1994
Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cellsC K Watts, K J Sweeney, A Warlters, et al.
The Journal of Biological Chemistry|April 18, 1997
Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2O W Prall, B Sarcevic, E A Musgrove, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and FosM L Handel, C K Watts, A deFazio, et al.
Molecular and Cellular Biology|April 7, 1998
Mechanisms of cyclin-dependent kinase inactivation by progestinsE A Musgrove, A Swarbrick, C S Lee, et al.
Oncogene|August 18, 2009
A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genesM Böhm, W J Locke, R L Sutherland, et al.
Journal of Cellular Biochemistry|June 1, 1996
High activity, soluble, bacterially expressed human vitamin D receptor and its ligand binding domainD G Mottershead, P Polly, R J Lyons, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|April 1, 1997
The third human isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) map position 10p14-p15J Nicholl, J A Hamilton, G R Sutherland, et al.
Pageof 21